References
- Baltimore City Health Department. (2017). Fentanyl. Retrieved from http://health.baltimorecity.gov/Fentanyl
- Baltimore City Health Department. (2018). Substance use and misuse. Retrieved from https://health.baltimorecity.gov/programs/substance-abuse
- Bardwell, G., Kerr, T., Boyd, J., & McNeil, R. (2018). Characterizing peer roles in an overdose crisis: Preferences for peer workers in overdose response programs in emergency shelters. Drug Alcohol Dependence, 190, 6–8. doi: 10.1016/j.drugalcdep.2018.05.023
- Carroll, J. J., Marshall, B. D. L., Rich, J. D., & Green, T. C. (2017). Exposure to fentanyl-contaminated heroin and overdose risk among illicit opioid users in Rhode Island: A mixed methods study. International Journal of Drug Policy, 46, 136–145. doi: 10.1016/j.drugpo.2017.05.023
- Ciccarone, D. (2009). Heroin in brown, black and white: Structural factors and medical consequences in the US heroin market. International Journal of Drug Policy, 20(3), 277–282. doi: 10.1016/j.drugpo.2008.08.003
- Ciccarone, D., Ondocsin, J., & Mars, S. G. (2017). Heroin uncertainties: Exploring users’ perceptions of fentanyl-adulterated and -substituted “heroin.” International Journal of Drug Policy, 46, 146–155. doi: 10.1016/j.drugpo.2017.06.004
- Dart, R. C., Surra, H. L., Cicero, T. J., Parrino, M. W., Severtson, S. G., Bucher-Bartelson, B., & Green, J. L. (2015). Trends in opioid analgesic abuse and mortality in the United States. New England Journal of Medicine, 372(3), 241–248. doi: 10.1056/NEJMsa1406143
- Davidson, P. J., Lopez, A. M., & Kral, A. H. (2018). Using drugs in un/safe spaces: Impact of perceived illegality on an underground supervised injecting facility in the United States. International Journal of Drug Policy, 53, 37–44. doi: 10.1016/j.drugpo.2017.12.005
- Fairbairn, N., Coffin, P. O., & Walley, A. Y. (2017). Naloxone for heroin, prescription opioid, and illicitly made fentanyl overdoses: Challenges and innovations responding to a dynamic epidemic. International Journal of Drug Policy, 46, 172–179. doi: 10.1016/j.drugpo.2017.06.005
- Fisher, R. J. (1993). Indirect questioning. Journal of Consumer Research, 20(2), 303–315. doi: 10.1086/209351
- Gladden, R. M., Martinez, P., & Seth, P. (2016). Fentanyl law enforcement submissions and increases in synthetic opioid-involved overdose deaths—27 states, 2013–2014. Morbidity and Mortality Weekly Report, 65(33), 837–843. doi: 10.15585/mmwr.mm6533a2
- Green, T. C., & Gilbert, M. (2016). Counterfeit medications and fentanyl. JAMA Internal Medicine, 176(10), 1555–1557.
- Hedegaard, H., Warner, M., & Miniño, A. M. (2017). Drug overdose deaths in the United States, 1999-2015. NCHS data brief, no 273. Hyattsville, MD: National Center for Health Statistics. Available from: https://www.cdc.gov/nchs/data/databriefs/db273.pdf.
- Kenney, S. R., Anderson, B. J., Conti, M. T., Bailey, G. L., & Stein, M. D. (2018). Expected and actual fentanyl exposure among persons seeking opioid withdrawal management. Journal of Substance Abuse Treatment, 86, 65–69.
- Kim, J. W. (2010). Aspiration of fentanyl patch. Journal of Addiction Medicine, 4(4), 244–245.
- Krieger, M. S., Yedinak, J. L., Buxton, J. A., Lysyshyn, M., Bernstein, E., & Rich, J. D. (2018). High willingness to use rapid fentanyl test strips among young adults who use drugs. Harm Reduction Journal, 15(1), 7.
- Kuczyńska, K., Grzonkowski, P., Kacprzak, Ł., & Zawilska, J. B. (2018). Abuse of fentanyl: An emerging problem to face. Forensic Science International, 289, 207–214.
- Kuhlman, J. J., McCaulley, R., Valouch, T. J., & Behonick, G. S. (2003). Fentanyl use, misuse, and abuse: A summary of 23 postmortem cases. Journal of Analytical Toxicology, 27(7), 499–504.
- Latkin, C., Davey-Rothwell, M., Yang, J. Y., & Crawford, N. (2013). The relationship between drug user stigma and depression among inner-city drug users in Baltimore, MD. Journal of Urban Health, 90(1), 147–156. doi: 10.1007/s11524-012-9753-z
- Latkin, C. A., Sherman, S. G., & Knowlton, A. (2003). HIV prevention among drug users: Outcome of a network-oriented peer outreach intervention. Journal of Health Psychology, 22(4), 332–339. doi: 10.1037/0278-6133.22.4.332
- Maddux, J. E., & Rogers, R. W. (1983). Protection motivation and self-efficacy: A revised theory of fear appeals and attitude change. Journal of Experimental Social Psychology, 19(5), 469–479. doi: 10.1016/0022-1031(83)90023-9
- Martins, S. S., Sampson, L., Cerdá, M., & Galea, S. (2015). Worldwide prevalence and trends in unintentional drug overdose: A systematic review of the literature. American Journal of Public Health, 105(11), e29–e49. doi: 10.2105/AJPH.2015.302843
- Mora-Ríos, J., Ortega-Ortega, M., & Medina-Mora, M. E. (2017). Addiction-related stigma and discrimination: A qualitative study in treatment centers in Mexico city. Substance Use Misuse, 52(5), 594–603. doi: 10.1037/0022-3514.53.2.298
- O'Donnell, J. K., Halpin, J., Mattson, C. L., Goldberger, B. A., & Gladden, R. M. (2017). Deaths involving fentanyl, fentanyl analogs, and U-47700—10 states, July-December 2016. Morbidity and Mortality Weekly Report, 66(43), 1197–1202.
- Prentice-Dunn, S., & Rogers, R. W. (1986). Protection motivation theory and preventive health: Beyond the health belief model. Health Education Research, 1(3), 153–161. doi: 10.1093/her/1.3.153
- Richards, J. R., Albertson, T. E., Derlet, R. W., Lange, R. A., Olson, K. R., & Horowitz, B. Z. (2015). Treatment of toxicity from amphetamines, related derivatives, and analogues: a systematic clinical review. Drug and Alcohol Dependence, 150, 1–13. doi: 10.1016/j.drugalcdep.2015.01.040.
- Rogers, E. M. (1995). Diffusion of innovations (4th ed.). New York, NY: The Free Press.
- Rogers, R. W. (1975). A protection motivation theory of fear appeals and attitude Change1. Journal of Psychology, 91(1), 93–114.
- Roxburgh, A., Hall, W. D., Dobbins, T., Gisev, N., Burns, L., Pearson, S., & Degenhardt, L. (2017). Trends in heroin and pharmaceutical opioid overdose deaths in Australia. Drug and Alcohol Dependence, 179, 291–298.
- Rudd, R. A., Seth, P., David, F., & Scholl, L. (2016). Increases in drug and opioid-involved overdose deaths—United States, 2010-2015. Morbidity and Mortality Weekly Report, 65(50–51), 1445–1452.
- Somerville, N. J., O'Donnell, J., Gladden, R. M., Zibbell, J. E., Green, T. C., Younkin, M., … Walley, A. Y. (2017). Characteristics of fentanyl overdose—Massachusetts, 2014-2016. Morbidity and Mortality Weekly Report, 66(14), 382–386.
- Sherman, S. G., Gann, D. S., Tobin, K. E., Latkin, C. A., Welsh, C., & Bielenson, P. (2009). “The life they save may be mine”: Diffusion of overdose prevention information from a city sponsored program. International Journal of Drug Policy, 20, 137–142. doi: 10.1016/j.drugpo.2008.02.004
- Stanley, T. H. (2014). The fentanyl story. Journal of Pain, 15(12), 1215–1226. doi: 10.1016/j.jpain.2014.08.010
- Winhusen, T., Theobald, J., Lewis, D., Wilder, C. M., & Lyons, M. S. (2016). Development and initial testing of a tailored telephone intervention delivered by peers to prevent recurring opioid-overdoses (TTIP-PRO). Health Education Research, 31(2), 146–160.
- Winnet, R., Anderson, E., Desiderato, L., Solomon, L., Perry, M., Kelly, J., … Lombard, T. N. (1995). Enhancing social diffusion theory as a basis for prevention intervention: A conceptual and strategic framework. Applied & Preventive Psychology, 4, 233–245. doi: 10.1016/S0962-1849(05)80025-3